The major objective of this project has been to study neutrophil function in health and disease. We have shown that a patient congenitally deficient in neutrophil specific granules has major abnormalities in neutrophil function. In normal neutrophils fmet-leu-phe receptors and C3bi receptors (CT3) are present in large amounts in an intracellular pool that cosediments with the specific granules from normal neutrophils on sucrose and Percoll gradients. These are translocated to the cell surface after activation of neurophils resulting in a three fold increase in fmet-leu-phe receptor and CR3. CR3 deficient patients' neutrophils have abnormal chemotaxis, adhesiveness and spreading. Studies comparing peripheral blood and experimental exudate cells in guinea pigs and in man it has shown that there is preferential loss of neutrophil specific granules in the exudate cells. In addition, exudate cells have incresed fmet-leu-phe and C3bi receptor expression. Cytochrome b, found in specific granules, is an important component of the electron transport chain essential for superoxide production. We have shown that neutrophil activation of the respiratory burst requires cytochrome b translocation from an intracellular compartment to the plasma membrane with activation by the calcium ionophore A23187 but not with activation by phorbol esters and fmet-leu-phe. Of 30 patients with chronic granulomatous disease, 11 had cytochrome b deficiency (10 were boys with an X-linked inheritance but interestingly one patient was a girl with probable autosomal recessive inheritance. In other studies of patients with hyper IgE syndrome (recurrent infections) we found that there is decrease catabolism of IgE in these patients.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Intramural Research (Z01)
Project #
1Z01AI000155-11
Application #
3960456
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
11
Fiscal Year
1986
Total Cost
Indirect Cost
Name
Niaid Extramural Activities
Department
Type
DUNS #
City
State
Country
United States
Zip Code
Sobhanie, Mahdee; Matsuoka, Yumiko; Jegaskanda, Sinthujan et al. (2016) Evaluation of the Safety and Immunogenicity of a Candidate Pandemic Live Attenuated Influenza Vaccine (pLAIV) Against Influenza A(H7N9). J Infect Dis 213:922-9
O'Donnell, Christopher D; Vogel, Leatrice; Matsuoka, Yumiko et al. (2014) The matrix gene segment destabilizes the acid and thermal stability of the hemagglutinin of pandemic live attenuated influenza virus vaccines. J Virol 88:12374-84
Baz, Mariana; Luke, Catherine J; Cheng, Xing et al. (2013) H5N1 vaccines in humans. Virus Res 178:78-98
Talaat, Kawsar R; Karron, Ruth A; Luke, Catherine J et al. (2011) An open label Phase I trial of a live attenuated H6N1 influenza virus vaccine in healthy adults. Vaccine 29:3144-8
Kuhns, Douglas B; Alvord, W Gregory; Heller, Theo et al. (2010) Residual NADPH oxidase and survival in chronic granulomatous disease. N Engl J Med 363:2600-10
Talaat, Kawsar R; Karron, Ruth A; Callahan, Karen A et al. (2009) A live attenuated H7N3 influenza virus vaccine is well tolerated and immunogenic in a Phase I trial in healthy adults. Vaccine 27:3744-53
Karron, Ruth A; Talaat, Kawsar; Luke, Catherine et al. (2009) Evaluation of two live attenuated cold-adapted H5N1 influenza virus vaccines in healthy adults. Vaccine 27:4953-60
Suguitan Jr, Amorsolo L; Marino, Michael P; Desai, Purvi D et al. (2009) The influence of the multi-basic cleavage site of the H5 hemagglutinin on the attenuation, immunogenicity and efficacy of a live attenuated influenza A H5N1 cold-adapted vaccine virus. Virology 395:280-8
Zarember, Kol A; Cruz, Anna R; Huang, Chiung-Yu et al. (2009) Antifungal activities of natural and synthetic iron chelators alone and in combination with azole and polyene antibiotics against Aspergillus fumigatus. Antimicrob Agents Chemother 53:2654-6
De Ravin, Suk See; Shum, Elaine; Zarember, Kol A et al. (2008) Short stature in partially corrected X-linked severe combined immunodeficiency--suboptimal response to growth hormone. J Pediatr Endocrinol Metab 21:1057-63

Showing the most recent 10 out of 30 publications